Julie Fox
0000-0002-0583-8019
Publication & Citation Trends
Publications
0 total
Broad and potent neutralizing antibodies are elicited in vaccinated individuals following Delta/BA.1 breakthrough infection OA
Cited by 8
Semantic Scholar
Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir
Cited by 2
Semantic Scholar
Incidence of hypertension and blood pressure changes in persons with HIV at high risk for cardiovascular disease switching from boosted protease inhibitors to dolutegravir: a post-hoc analysis of the 96-week randomised NEAT-022 trial.
Cited by 15
Semantic Scholar
Proteomic Analysis of Mucosal and Systemic Responses to SARS-CoV-2 Antigen OA
Cited by 4
Semantic Scholar
Behaviour changes following HIV diagnosis among men who have sex with men in the era of treatment as prevention: data from a prospective study OA
Cited by 3
Semantic Scholar
Re‐valuation of annual cytology using HPV self‐sampling to upgrade prevention (REACH UP): A feasibility study in women living with HIV in the UK OA
Cited by 4
Semantic Scholar
A highly virulent variant of HIV-1 circulating in the Netherlands OA
Cited by 61
Semantic Scholar
UK guideline for the use of HIV post‐exposure prophylaxis 2021 OA
Cited by 38
Semantic Scholar
Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency Virus OA
Cited by 13
Semantic Scholar
GSTM1 Copy Number and Kidney Disease in People With HIV OA
Cited by 3
Semantic Scholar
Research Topics
HIV/AIDS Research and Interventions
(134)
HIV Research and Treatment
(114)
HIV/AIDS drug development and treatment
(82)
HIV-related health complications and treatments
(49)
HIV, Drug Use, Sexual Risk
(45)
Affiliations
University of North Carolina at Chapel Hill
National Health Service
University of Iowa
Pennine Acute Hospitals NHS Trust
Rush University Medical Center